| abstract |
The present invention relates to artificial nucleic acids, particularly artificial RNAs suitable for the treatment and/or prevention of respiratory syncytial virus (RSV) infection or conditions associated with such infection. The present invention also relates to a method of treating or preventing a disorder or disease, a first medical use and a second medical use of the artificial RNA, compositions and vaccines. Furthermore, the present invention relates to kits, in particular kits of kits, comprising artificial RNAs, compositions and vaccines. |